BackCelyad Oncology Overview

Celyad Oncology Intangible Assets

Latest intangible assets for CYAD: $26K.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$26000.00
95.97% YoYΔ $-619000.00 vs prior year quarter

Peer average

Loading

Celyad Oncology Intangible Assets History

Loading

Celyad Oncology vs. peers: Intangible Assets Comparison

Loading

Celyad Oncology Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Celyad Oncology (CYAD) FAQ

As of the most recent data (June 2024), CYAD shows a intangible assets of $26K. That compares with $650K in the prior-year period — down 96.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYAD's intangible assets is now $26K (was $650K) — a 96.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Celyad Oncology is outperforming or lagging.

Tracking CYAD's intangible assets over time shows whether Celyad Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $26K That compares with $650K in the prior-year period — down 96.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Celyad Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $26K) with ownership activity and broader fundamentals.

Celyad Oncology's intangible assets is $26K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.